Fraunhofer Institute for Cell Therapy and Immunology IZIDr. Kristin Reiche appointed Professor of Digital Molecular Medicine at IT:U
On February 1, 2026, Dr. Kristin Reiche, Head of the Medical Bioinformatics Department at the Fraunhofer Institute for Cell Therapy and Immunology IZI, was appointed Professor of Digital Molecular Medicine at the Interdisciplinary Transformation University (IT:U).
Together with her team at Fraunhofer IZI in Leipzig, Professor Reiche develops computer-based and data-driven technologies for the next generation of precision medicine – particularly for the treatment of cancer and autoimmune diseases. Her research combines bioinformatics methods with multimodal single-cell analysis to create innovative molecular diagnostic tools.
Professor Reiche studied computer science and medical informatics in Leipzig and Liverpool. Before joining Fraunhofer IZI, she worked at the Helmholtz Centre for Environmental Research (UFZ) and the Institute for Clinical Immunology at the University of Leipzig’s Medical Faculty. In her current position, she coordinates the Horizon Europe project CERTAINTY, in which an international consortium is developing a virtual twin to improve the personalization of cancer immunotherapies.
The Interdisciplinary Transformation University (IT:U), which is currently being established and has its campus in Linz, Austria, was founded in July 2022. It is one of the first European universities dedicated entirely to the digital transformation of science, business, and society. Its project-based, integrative approach equips students across disciplines with the digital expertise needed to address global challenges. The university’s focus lies at the intersection of disciplinary knowledge and the application of artificial intelligence (AI) and digital technologies. As a founding professor at IT:U, Professor Reiche will contribute her expertise in application-oriented research, with a focus on molecular medicine – particularly immuno-oncology and infectious pathology.
